|
gptkbp:instanceOf
|
gptkb:species
protozoan parasite
|
|
gptkbp:annualDeaths
|
over 400,000
|
|
gptkbp:antibioticResistance
|
gptkb:artemisinin
gptkb:sulfadoxine-pyrimethamine
chloroquine
|
|
gptkbp:cause
|
malaria
cerebral malaria
|
|
gptkbp:class
|
gptkb:Aconoidasida
|
|
gptkbp:discoveredBy
|
gptkb:Alphonse_Laveran
|
|
gptkbp:diseaseBurden
|
most deadly malaria parasite
|
|
gptkbp:distribution
|
gptkb:South_America
gptkb:Southeast_Asia
gptkb:sub-Saharan_Africa
tropical regions
|
|
gptkbp:family
|
gptkb:Plasmodiidae
|
|
gptkbp:firstDescribed
|
1880
|
|
gptkbp:genomeSize
|
23 megabases
|
|
gptkbp:genus
|
gptkb:Plasmodium
|
|
gptkbp:hostedBy
|
gptkb:Homo_sapiens
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Plasmodium falciparum
|
|
gptkbp:infects
|
humans
red blood cells
|
|
gptkbp:kingdom
|
gptkb:Protista
|
|
gptkbp:lifeCycle
|
gptkb:merozoite
gptkb:sporozoite
gametocyte
|
|
gptkbp:locatedOnChromosome
|
14
|
|
gptkbp:notable_for
|
gptkb:kelch13
gptkb:pfcrt
gptkb:pfmdr1
|
|
gptkbp:notableFor
|
gptkb:HRP2
gptkb:MSP1
gptkb:PfEMP1
|
|
gptkbp:numberOfCases
|
over 200 million
|
|
gptkbp:order
|
gptkb:Haemosporida
|
|
gptkbp:phylum
|
gptkb:Apicomplexa
|
|
gptkbp:prevention
|
insecticide-treated nets
indoor residual spraying
|
|
gptkbp:resequencedGenome
|
2002
|
|
gptkbp:studiedBy
|
malariologists
|
|
gptkbp:transmittedBy
|
gptkb:Anopheles_mosquito
|
|
gptkbp:treatment
|
gptkb:atovaquone-proguanil
gptkb:mefloquine
quinine
artemisinin-based combination therapy
|
|
gptkbp:vaccineTarget
|
gptkb:RTS,S
|
|
gptkbp:vectorFor
|
gptkb:Anopheles_funestus
gptkb:Anopheles_gambiae
|
|
gptkbp:WHOClassification
|
Group 1 carcinogen (malaria)
|
|
gptkbp:bfsParent
|
gptkb:Malaria
|
|
gptkbp:bfsLayer
|
4
|